BioCentury
ARTICLE | Clinical News

Cavosonstat: Completed Phase II enrollment

July 18, 2016 7:00 AM UTC

Nivalis completed enrollment of 138 patients who have 2 copies of the F508del mutation in the CF transmembrane conductance regulatory ( CFTR) gene in a double-blind, placebo-controlled, U.S. Phase II ...